Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
EU

NASDAQ · EUDAW

EUDA Health Holdings Limited

Healthcare · Medical - Healthcare Information Services

$0.04

Down-$0.01 (-36.83%)

Updated Sep 13, 2026, 7:28 PM

SID Score

3.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
3.69M
P/E ratio
306.55
Dividend yield
0.00%
52-week range
$0.01 – $0.30
Volume
504.51
Avg. volume
6.38K

Price performance

EUDAW price history

1M range · 16 trading sessions · Daily adjusted prices

EUDAW closed at $0.04 after 16 trading sessions, up 18.06% for the selected period.

Last close
$0.04
Period change
+18.06%
Period low
$0.02
Period high
$0.04
Daily close
View OHLC price history
EUDAW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$0.0353$0.0353$0.0353$0.0353504.51
Sep 9, 2026$0.0223$0.0353$0.0223$0.03531K
Sep 8, 2026$0.0349$0.0354$0.0223$0.03541.08K
Sep 4, 2026$0.0298$0.0349$0.0298$0.02989.74K
Sep 3, 2026$0.0223$0.0223$0.0223$0.02234.02K
Sep 2, 2026$0.0224$0.0299$0.0223$0.0299671.11
Sep 1, 2026$0.0223$0.0299$0.0223$0.0299488
Aug 31, 2026$0.0279$0.0299$0.0279$0.02996.02K
Aug 28, 2026$0.0221$0.0279$0.0221$0.0279550
Aug 27, 2026$0.0298$0.0298$0.0298$0.0298300
Aug 25, 2026$0.0222$0.0299$0.0222$0.0299636.32
Aug 21, 2026$0.0279$0.0299$0.0279$0.0299769.22
Aug 20, 2026$0.0279$0.0299$0.0279$0.0299400
Aug 19, 2026$0.0219$0.0299$0.0219$0.02653.46K
Aug 18, 2026$0.0218$0.0219$0.0218$0.02192.01K
Aug 17, 2026$0.0299$0.0299$0.0299$0.0299101

Latest EUDAW news

The latest Smart Investors Daily articles mentioning EUDAW.

Stock researchCompany · Overview

EUDAW research

Overview

Company profile and research snapshot.

Company profile

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 30, 2026

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the integrated cell therapy program to be pursued under its recently announced non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Imm

Yahoo · Jul 28, 2026

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today announced that it has signed a Memorandum of Understanding (“MOU”) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. (“SIIT”) to establish a tri-party collaboration with next-generation therap

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By